Compare LI & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LI | WST |
|---|---|---|
| Founded | 2015 | 1923 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 20.2B |
| IPO Year | 2020 | N/A |
| Metric | LI | WST |
|---|---|---|
| Price | $17.01 | $271.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $20.91 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 4.7M | 704.0K |
| Earning Date | 11-26-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | 0.62 | ★ 6.75 |
| Revenue | ★ $17,952,966,790.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | $26.73 | $6.20 |
| P/E Ratio | ★ $26.05 | $39.79 |
| Revenue Growth | N/A | ★ 4.92 |
| 52 Week Low | $16.11 | $187.43 |
| 52 Week High | $33.12 | $348.90 |
| Indicator | LI | WST |
|---|---|---|
| Relative Strength Index (RSI) | 39.90 | 49.65 |
| Support Level | $16.11 | $264.92 |
| Resistance Level | $17.45 | $275.56 |
| Average True Range (ATR) | 0.36 | 7.46 |
| MACD | 0.05 | -0.39 |
| Stochastic Oscillator | 49.76 | 34.84 |
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.